Jun 2026· Mediterranean Journal of Rheumatology· Vol 37, pp. 562 - 574· 0 citations· 71 references
Medicine
TL;DR
This is the first descriptive study of SSc in Jordan, highlighting a significant burden of organ involvement, comorbidities, and functional disability in this understudied population.
Abstract
Objective: To describe the clinical and demographic characteristics of systemic sclerosis (SSc) in a Jordanian cohort and assess patients’ psychological well-being, quality of life, and functional disability. Methods: This cross-sectional study included all consecutive SSc patients seen at a single rheumatology clinic at Jordan University Hospital, Amman, between January and October 2023. Demographic and clinical data were collected via a structured questionnaire. Depression was assessed with the PHQ-9, and fibromyalgia screening with the FiRST questionnaire. Disease activity was measured using the modified Rodnan Skin Score (mRSS) and Scleroderma Health Assessment Questionnaire (SHAQ), disability with the Cochin Hand Function Scale (CHFS), and quality of life with the SF-36. Results: Fifty-seven patients were enrolled; mean age 50.7 ± 12.9 years, 53 (93.0%) female. Thirty-two (56.1%) had limited SSc, and 25 (43.9%) had diffuse disease. Raynaud’s phenomenon was present in 49 (86.0%), digital ulcers in 28 (49.1%), and interstitial lung disease in 14 (24.6%). Pulmonary arterial hypertension was identified in 16 (28.1%). Microstomia was observed in 44 (77.2%) and gastroesophageal reflux in 21 (36.8%). Among 43 patients with DXA scans, 11 (19.3% of total cohort) had osteopenia and 7 (12.3%) osteoporosis.SF-36 physical and mental component scores were similarly impaired across subtypes. Only 1 patient (1.8%) met criteria for mild depression, and none met criteria for fibromyalgia. Conclusion: This is the first descriptive study of SSc in Jordan, highlighting a significant burden of organ involvement, comorbidities, and functional disability in this understudied population.
Background
. Juvenile scleroderma (JS) is a rare systemic autoimmune connective tissue disease with onset in childhood, characterized by involvement of the skin, musculoskeletal system and, in the systemic form, internal organs. The severity of inflammation, fibrotic changes and functional limitations leads to a dec...
J. S. Bogomolova, G. Santalova· Pediatric pharmacology· 0 citations
Background: Rheumatoid arthritis is increasingly recognized as a global health burden. The global prevalence has increased markedly. It impairs daily activities, psychosocial patterns, and, hence, overall quality of life. Objective: To assess the overall quality of life of rheumatoid arthritis patients compared with a...
A. Albayati, L. Hameed· Al-Rafidain Journal of Medic...· 0 citations
INTRODUCTION
Multimorbidity is frequent in rheumatoid arthritis (RA) and is associated with increased mortality, impaired quality of life, and complex clinical management. However, its association with hospitalization characteristics, particularly hospital length of stay and reasons for admission, remains insufficientl...
G. Ghoullam, I. El Binoune, B. Amine et al.· Current Rheumatology Reviews· 0 citations
OBJECTIVES
To characterize clinical manifestations, major organ involvement, real-world treatment patterns, and factors associated with severity classification in Japanese patients with mixed connective tissue disease (MCTD), aiming to clarify its heterogeneous clinical spectrum.
METHODS
This nationwide retrospective...
S. Kubo, Yurie Kanda, Hideto Kameda et al.· Rheumatology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.